Clinical efficacy of the novel thiazolidinedione lobeglitazone in patients with type 2 diabetes

被引：7
|
作者：
Lee, J. -Y. [1 ,2 ]
Cho, Y. [1 ,2 ]
Lee, M. [1 ,2 ]
Lee, Y. -H. [1 ,2 ,3 ]
Lee, B. -W. [1 ,2 ,3 ]
Kang, E. S. [1 ,2 ,3 ]
Cha, B. -S. [1 ,2 ,3 ]
机构：
[1] Yonsei Univ, Dept Internal Med, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea
[2] Yonsei Univ, Grad Sch, Coll Med, Seoul, South Korea
[3] Yonsei Univ, Inst Endocrine Res, Coll Med, Seoul, South Korea
来源：
DIABETES & METABOLISM | 2018年 / 44卷 / 05期
关键词：
INSULIN-RESISTANCE; DOUBLE-BLIND; PIOGLITAZONE; TOLERABILITY; METFORMIN; THERAPY; VILDAGLIPTIN; MONOTHERAPY; 24-WEEK;
D O I：
10.1016/j.diabet.2017.11.005
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：452 / 455
页数：4
相关论文
共 50 条
  • [1] Efficacy and safety of novel thiazolidinedione lobeglitazone for managing type-2 diabetes a meta-analysis
    Dutta, Deep
    Bhattacharya, Saptarshi
    Kumar, Manoj
    Datta, Priyankar K.
    Mohindra, Ritin
    Sharma, Meha
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2023, 17 (01)
  • [2] Lobeglitazone: A Novel Thiazolidinedione for the Management of Type 2 Diabetes Mellitus
    Bae, Jaehyun
    Park, Taegyun
    Kim, Hyeyoung
    Lee, Minyoung
    Cha, Bong-Soo
    DIABETES & METABOLISM JOURNAL, 2021, 45 (03) : 326 - 336
  • [3] Comparative Efficacy of Lobeglitazone Versus Pioglitazone on Albuminuria in Patients with Type 2 Diabetes Mellitus
    Kim, Kyung-Soo
    Hong, Sangmo
    Ahn, Hong-Yup
    Park, Cheol-Young
    DIABETES THERAPY, 2021, 12 (01) : 171 - 181
  • [4] Effects of Lobeglitazone, a Novel Thiazolidinedione, on Bone Mineral Density in Patients with Type 2 Diabetes Mellitus over 52 Weeks
    Lim, Soo
    Kim, Kyoung Min
    Kim, Sin Gon
    Kim, Doo Man
    Woo, Jeong-Taek
    Chung, Choon Hee
    Ko, Kyung Soo
    Park, Jeong Hyun
    Park, Yongsoo
    Kim, Sang Jin
    Jang, Hak Chul
    Choi, Dong Seop
    DIABETES & METABOLISM JOURNAL, 2017, 41 (05) : 377 - 385
  • [5] Lobeglitazone, a Novel Thiazolidinedione, Improves Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes: Its Efficacy and Predictive Factors Related to Responsiveness
    Lee, Yong-ho
    Kim, Jae Hyeon
    Kim, So Ra
    Jin, Heung Yong
    Rhee, Eun-Jung
    Cho, Young Min
    Lee, Byung-Wan
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2017, 32 (01) : 60 - 69
  • [6] Comparative Efficacy of Lobeglitazone Versus Pioglitazone on Albuminuria in Patients with Type 2 Diabetes Mellitus
    Kyung-Soo Kim
    Sangmo Hong
    Hong-Yup Ahn
    Cheol-Young Park
    Diabetes Therapy, 2021, 12 : 171 - 181
  • [7] Safety and efficacy of lobeglitazone monotherapy in patients with type 2 diabetes mellitus over 52 weeks: An open-label extension study
    Kim, Sun Hwa
    Kim, Sin Gon
    Kim, Doo Man
    Woo, Jeong-Taek
    Jang, Hak Chul
    Chung, Choon Hee
    Ko, Kyung Soo
    Park, Jeong Hyun
    Park, Yong Soo
    Kim, Sang Jin
    Choi, Dong Seop
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2015, 110 (03) : E27 - E30
  • [8] Efficacy and safety of sitagliptin in patients with type 2 diabetes mellitus: a meta-analysis
    Zhao, Jun-Yu
    Wang, Hai-Peng
    Wang, Huan-Jun
    Yao, Jin-Ming
    Wu, Xiao-Yun
    Dong, Jian-Jun
    Liao, Lin
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (06): : 11202 - 11210
  • [9] Efficacy and tolerability of vildagliptin as an add-on to glimepiride in Japanese patients with Type 2 diabetes mellitus
    Kikuchi, Masatoshi
    Haneda, Masakazu
    Koya, Daisuke
    Tobe, Kazuyuki
    Onishi, Yukiko
    Couturier, Andre
    Mimori, Nobuyuki
    Inaba, Yoko
    Goodman, Matthew
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2010, 89 (03) : 216 - 223
  • [10] Effect of Dapagliflozin in Combination with Lobeglitazone and Metformin in Korean Patients with Type 2 Diabetes in Real-World Clinical Practice
    Seo, Da Hea
    Suh, Young Ju
    Cho, Yongin
    Ahn, Seong Hee
    Seo, Seongha
    Hong, Seongbin
    Lee, Yong-Ho
    Choi, Young Ju
    Lee, Eunjig
    Kim, So Hun
    YONSEI MEDICAL JOURNAL, 2022, 63 (09) : 825 - 833
12345